Abstract
A New Prediction Model for Distinguishing Skin Sensitizers Based on Il-18 Release from Reconstructed Epidermis: Enhancing the Assessment of a Key Event in the Skin Sensitization Adverse Outcome Pathway
This is a members-only content. Please log in to access it.